PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16156795-5	2005	15d-PGJ2 suppression of Prm3 transcriptional activity and TPbeta mRNA expression was found to occur through a novel mechanism involving direct binding of PPARgamma-retinoic acid X receptor (RXR) heterodimers to a PPARgamma response element (PPRE) composed of two imperfect hexameric direct repeat (DR) sequences centred at -159 and -148, respectively, spaced by five nucleotides (DR5).	9-deoxy-delta-9-prostaglandin D2	4-8	retinoid X receptor alpha	Homo sapiens	154-188	
16156795-5	2005	15d-PGJ2 suppression of Prm3 transcriptional activity and TPbeta mRNA expression was found to occur through a novel mechanism involving direct binding of PPARgamma-retinoic acid X receptor (RXR) heterodimers to a PPARgamma response element (PPRE) composed of two imperfect hexameric direct repeat (DR) sequences centred at -159 and -148, respectively, spaced by five nucleotides (DR5).	9-deoxy-delta-9-prostaglandin D2	4-8	retinoid X receptor alpha	Homo sapiens	190-193	
15150131-10	2004	PGJ2 + RA increased the binding of the PPARgamma - RXR heterodimer to the putative PPAR-response elements (PPREs) in the GSTA2 promoter.	9-deoxy-delta-9-prostaglandin D2	0-4	retinoid X receptor alpha	Homo sapiens	51-54	
15150131-12	2004	Transactivation of PPREM by the PPARgamma - RXR heterodimer was verified by the effective GSTA2 induction in the cells treated with PGJ2 + RA after transfecting them with the plasmids encoding PPARgamma1 and RXRalpha.	9-deoxy-delta-9-prostaglandin D2	132-136	retinoid X receptor alpha	Homo sapiens	44-47	
15150131-12	2004	Transactivation of PPREM by the PPARgamma - RXR heterodimer was verified by the effective GSTA2 induction in the cells treated with PGJ2 + RA after transfecting them with the plasmids encoding PPARgamma1 and RXRalpha.	9-deoxy-delta-9-prostaglandin D2	132-136	retinoid X receptor alpha	Homo sapiens	208-216	
10935488-6	1999	Addition of the RXRalpha ligands, 9-cis-RA or LG100268, sensitized T24 bladder cancer cells to the lethal effect of troglitazone and two other PPAR- activators, ciglitazone and 15-deoxy-delta(12,14)-PGJ2 (15dPGJ(2)).	9-deoxy-delta-9-prostaglandin D2	199-203	retinoid X receptor alpha	Homo sapiens	16-24